Early research (Phase 1)Study completedNCT02248090What this trial is testingAZD9496 First Time in Patients Ascending Dose StudyWho this might be right forER+ HER2- Advanced Breast Cancer AstraZeneca 45
Early research (Phase 1)Active Not RecruitingNCT03332797What this trial is testingGDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 181
Not applicableStudy completedNCT06830486What this trial is testingEffects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)Who this might be right forBreast Cancer University of Colorado, Denver 40
Early research (Phase 1)Active Not RecruitingNCT05870579What this trial is testing[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 28
Not applicableLooking for participantsNCT07262138What this trial is testingActive Surveillance in Older Women With ER+ Breast CancerWho this might be right forEarly Stage Estrogen Receptor (ER) Positive Breast Cancer University of Pittsburgh 50
Testing effectiveness (Phase 2)Study completedNCT03106077What this trial is testingMirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast CancerWho this might be right forAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+18 more M.D. Anderson Cancer Center 96
Not applicableUnknownNCT05057000What this trial is testingEffect of Aerobic Exercises and Nutrition In Adolescent Girls With AnorexiaWho this might be right forAnorexia in Adolescence Badr University 30
Testing effectiveness (Phase 2)Study completedNCT00755885What this trial is testingAbiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Cancer Research UK 77
Large-scale testing (Phase 3)Study completedNCT00393172What this trial is testingWomen in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]Who this might be right forBreast CancerObesity University of Minnesota 400
Not applicableNot Yet RecruitingNCT07212712What this trial is testingThe Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in HumansWho this might be right forCerebral Blood FlowCerebral Blood Flow RegulationSex Differences+2 more University of British Columbia 50
Early research (Phase 1)Looking for participantsNCT07029399What this trial is testingA Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forHR+ Breast CancerTriple Negative Breast Cancer (TNBC)CCNE1 Amplified Advanced Solid Tumors+1 more NiKang Therapeutics, Inc. 361
Not applicableStudy completedNCT02927392What this trial is testingBrown Adipose Tissue Activity in Pre- and Postmenopausal WomenWho this might be right forMenopauseObesity University of Colorado, Denver 69
Testing effectiveness (Phase 2)Study completedNCT00444535What this trial is testingLapatinib and Bevacizumab for Metastatic Breast CancerWho this might be right forNeoplasms, Breast Novartis Pharmaceuticals 52
Not applicableStudy completedNCT00001770What this trial is testingProgestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)Who this might be right forDepressive DisorderMood DisorderPsychomotor Agitation National Institute of Mental Health (NIMH) 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06428396What this trial is testingStudy of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)Who this might be right forMetastatic Breast Cancer Merck Sharp & Dohme LLC 120
Early research (Phase 1)Active Not RecruitingNCT05654532What this trial is testingStudy of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Accutar Biotechnology Inc 100
Large-scale testing (Phase 3)Looking for participantsNCT06530459What this trial is testingThe MUSE Study for Menopausal ArthralgiaWho this might be right forArthralgiaMenopausePerimenopausal Disorder+2 more National University Hospital, Singapore 100
Testing effectiveness (Phase 2)Ended earlyNCT01616758What this trial is testingPhase II Study of GTx024 in Women With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer GTx 22
Not applicableLooking for participantsNCT07022340What this trial is testingHemodynamics After Resistance TrainingWho this might be right forPerimenopause University of Michigan 50
Testing effectiveness (Phase 2)Looking for participantsNCT07100106What this trial is testingEvaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 285